Amlodipine/Bisoprolol fumarate/Perindopril arginine

氨氯地平/富马酸比索洛尔/精氨酸培哚普利

Report date: 2022/03/08 16:45:33

Base Information

Drug NameAmlodipine/Bisoprolol fumarate/Perindopril arginine
Drug Alias NameAmlodipine+Bisoprolol fumarate+Perindopril arginine氨氯地平+富马酸比索洛尔+精氨酸培哚普利S-05166
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin-converting enzyme inhibitorsBeta-1 adrenergic receptor antagonists
TargetsVoltage-gated calcium channelAngiotensin-converting enzymeBeta-1 adrenergic receptor
Therapy Area/IndicationsHypertensionCoronary Artery DiseaseMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Amlodipine BesylatePerindopril ArginineBisoprolol Fumarate
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesLes Laboratoires Servier
Inactive CompaniesN/A
Active IndicationsHypertensionCoronary Artery DiseaseMyocardial Ischemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A